Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder

Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder

Abstract Background Sulforaphane (SF), an isothiocyanate in broccoli, has potential benefits relevant to autism spectrum disorder (ASD) through its effects on several metabolic and immunologic pathways. Previous clinical trials of oral SF demonstrated positive clinical effects on behavior in young m...

Full description

Bibliographic Details
Main Authors: Andrew W. Zimmerman, Kanwaljit Singh, Susan L. Connors, Hua Liu, Anita A. Panjwani, Li-Ching Lee, Eileen Diggins, Ann Foley, Stepan Melnyk, Indrapal N. Singh, S. Jill James, Richard E. Frye, Jed W. Fahey
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Molecular Autism
Subjects:
Sulforaphane
Clinical trial
Autism spectrum disorder (ASD)
Biomarkers
Placebo effects
Online Access:https://doi.org/10.1186/s13229-021-00447-5

Internet

https://doi.org/10.1186/s13229-021-00447-5

Similar Items